Cutaneous Lupus Erythematosus (CLE) Clinical Trials

6 recruitingLast updated: July 25, 2026

There are 6 actively recruiting cutaneous lupus erythematosus (cle) clinical trials across 11 countries. Studies span Phase 2, Phase 1, Phase 3. Top locations include Tampa, Florida, United States, Allen, Texas, United States, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Cutaneous Lupus Erythematosus (CLE) Trials at a Glance

6 actively recruiting trials for cutaneous lupus erythematosus (cle) are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Tampa, Allen, and Atlanta. Lead sponsors running cutaneous lupus erythematosus (cle) studies include Beijing InnoCare Pharma Tech Co., Ltd., EMD Serono Research & Development Institute, Inc., and Lupus Foundation of America.

Browse cutaneous lupus erythematosus (cle) trials by phase

Treatments under study

About Cutaneous Lupus Erythematosus (CLE) Clinical Trials

Looking for clinical trials for Cutaneous Lupus Erythematosus (CLE)? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cutaneous Lupus Erythematosus (CLE) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cutaneous Lupus Erythematosus (CLE) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.202 enrolled13 locationsNCT07332481
Recruiting
Phase 2

Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study

Cutaneous Lupus Erythematosus (CLE)
Beijing InnoCare Pharma Tech Co., Ltd.105 enrolled27 locationsNCT07440537
Recruiting
Phase 1

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Psoriasis (PsO)+3 more
Seismic Therapeutic AU Pty Ltd24 enrolled2 locationsNCT07455578
Recruiting
Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Systemic Lupus ErythematosusSLESLE (Systemic Lupus)+2 more
Ventus Therapeutics U.S., Inc.24 enrolled27 locationsNCT07260877
Recruiting

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania700 enrolled2 locationsNCT01510067
Recruiting

Research Accelerated by You Lupus Registry

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)
Lupus Foundation of America10,000 enrolled1 locationNCT06927219